This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche
Leukemia Open Access 21 March 2024
-
Comparison of the effects of high dietary iron levels on bone microarchitecture responses in the mouse strains 129/Sv and C57BL/6J
Scientific Reports Open Access 28 February 2024
-
The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies
Bone Research Open Access 14 March 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bulycheva E, Rauner M, Medyouf H, Theurl I, Bornhäuser M, Hofbauer LC et al. Myelodysplasia is in the niche: novel concepts and emerging therapies. Leukemia 2015; 29: 259–268.
Ferrer RA, Wobus M, List C, Wehner R, Schonefeldt C, Brocard B et al. Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide. Haematologica 2013; 98: 1677–1685.
Geyh S, Öz S, Cadeddu R-P, Fröbel J, Brückner B, Kündgen A et al. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells. Leukemia 2013; 27: 1841–1851.
Balderman SR, Li AJ, Hoffman CM, Frisch BJ, Goodman AN, LaMere MW et al. Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome. Blood 2016; 127: 616–625.
Raaijmakers MHGP, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010; 464: 852–857.
Pittenger MF . Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.
Lin Y, Slape C, Zhang Z, Aplan PD . NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood 2005; 106: 287–295.
Medyouf H, Mossner M, Jann JC, Nolte F, Raffel S, Herrmann C et al. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell 2014; 14: 824–837.
Schmitt J, Schwarz K, Baurecht H, Hotze M, Fölster-Holst R, Rodríguez E et al. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol 2016; 137: 130–136.
Trautmann F, Schuler M, Schmitt J . Burden of soft-tissue and bone sarcoma in routine care. Cancer Epidemiol 2015; 39: 440–446.
Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JCG et al. Thalassemia bone disease: A 19-year longitudinal analysis. J Bone Miner Res 2014; 29 (S1): 2468–2473.
Petryk A, Polgreen LE, Barnum JL, Zhang L, Hodges JS, Baker KS et al. Bone mineral density in children with fanconi anemia after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2015; 21: 894–899.
Korkmaz U, Korkmaz N, Yazici S, Erkan M, Baki AE, Yazici M et al. Anemia as a risk factor for low bone mineral density in postmenopausal Turkish women. Eur J Intern Med 2012; 23: 154–158.
Rutten EPA, Franssen FME, Spruit MA, Wouters EFM . Anemia is associated with bone mineral density in chronic obstructive pulmonary disease. COPD 2013; 10: 286–292.
Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O’Malley CD . Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 2014; 9: 182.
Acknowledgements
This work was supported by the José Carreras foundation to MR and UP (DJCLS R 13/15), a grant from the Deutsche Forschungsgemeinschaft (DFG SFB-655) to LCH and UP, a grant of the Elsbeth Bonhoff foundation to UP and LCH, and the Deutsche Konsortium für Translationale Krebsforschung (DKTK) to LCH, MB and UP. The authors thank T Datzmann and F Tesch for the statistical analysis of the human data. We thank the Saxony Health Insurance AOK PLUS for the cooperation in data utilisation and for providing technical support.
Author contributions
HW, MR, LCH and UP designed the study. HW, FT, JS, MR, EB and UB performed experiments and analyzed the results. LCH, MB and CK contributed tools, HW, MR, LCH and UP wrote the manuscript and all authors critically read and approved the letter.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Weidner, H., Rauner, M., Trautmann, F. et al. Myelodysplastic syndromes and bone loss in mice and men. Leukemia 31, 1003–1007 (2017). https://doi.org/10.1038/leu.2017.7
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.7
This article is cited by
-
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche
Leukemia (2024)
-
Comparison of the effects of high dietary iron levels on bone microarchitecture responses in the mouse strains 129/Sv and C57BL/6J
Scientific Reports (2024)
-
The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies
Bone Research (2023)
-
Extracellular vesicle-mediated remodeling of the bone marrow microenvironment in myeloid malignancies
International Journal of Hematology (2023)
-
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
Leukemia (2022)